Tuesday, April 24, 2018

Amgen Revises 2018 Guidance - Quick Facts

Amgen (AMGN) announced, for the full year 2018, the company now expects: on a non-GAAP basis, EPS in the range of $12.80 to $13.70. Previously, the company expected non-GAAP EPS in the range of $12.60 to $13.70. The company now expects total revenues in the range of $21.9 billion to $22.8 billion. Previously, the company expected total revenues in the range of $21.8 billion to $22.8 billion.

from RTT - Earnings https://ift.tt/2Fh2gM8
via IFTTT

No comments:

Post a Comment